Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Option Care Health (OPCH) EBITDA (2016 - 2026)

Option Care Health (OPCH) has disclosed EBITDA for 18 consecutive years, with $44.6 million as the latest value for Q1 2026.

  • For Q1 2026, EBITDA rose 0.6% year-over-year to $44.6 million; the TTM value through Mar 2026 reached $200.9 million, down 2.42%, while the annual FY2025 figure was $200.6 million, 3.49% down from the prior year.
  • EBITDA hit $44.6 million in Q1 2026 for Option Care Health, down from $57.1 million in the prior quarter.
  • Across five years, EBITDA topped out at $117.7 million in Q2 2023 and bottomed at $35.8 million in Q1 2023.
  • Average EBITDA over 5 years is $52.1 million, with a median of $48.1 million recorded in 2022.
  • Year-over-year, EBITDA soared 3288.93% in 2022 and then tumbled 55.7% in 2024.
  • Option Care Health's EBITDA stood at $44.2 million in 2022, then grew by 15.66% to $51.1 million in 2023, then grew by 20.71% to $61.7 million in 2024, then decreased by 7.41% to $57.1 million in 2025, then dropped by 21.88% to $44.6 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods came in at $44.6 million, $57.1 million, and $50.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.